BROAD-SPECTRUM MULTI-ANTIGEN PAN-CORONAVIRUS VACCINE

CH505 ENVELOPES TO ENGAGE AND MATURE CD4 BINDING SITE NEUTRALIZING ANTIBODIES

MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES

COMBINATION VACCINES AGAINST CORONAVIRUS INFECTION, INFLUENZA INFECTION, AND/OR RSV INFECTION

DENGUE VACCINE FORMULATION

SHIGELLA MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION AND FUSION PROTEINS THEREOF

VACCINE AGAINST KLEBSIELLA PNEUMONIAE

VARIANT STRAIN-BASED CORONAVIRUS VACCINES

VACCINATION AGAINST PNEUMOCCOCAL AND COVID-19 INFECTIONS

PAN-SARBECOVIRUS NANOPARTICLE VACCINES

NUCLEIC ACID-BASED UNIVERSAL VACCINE AND METHODS OF USE THEREOF

INFLUENZA VIRUS VACCINES

SYNTHETIC MULTIVALENT TUBERCULOSIS VACCINE

NINE-COMPONENT ANTIGEN AFRICAN SWINE FEVER SUBUNIT VACCINE

MULTIEPITOPE UNIVERSAL INFLUENZA VACCINE

RHINOVIRUS MRNA VACCINE

NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF

MULTIVALENT PNEUMOCOCCAL VACCINES

MULTIPLE ANTIGEN PRESENTING SYSTEM (MAPS) CROSS-LINKED USING A BIFUNCTIONAL FUSION PROTEIN AND ITS USE IN VACCINES PROTEIN AND ITS USE IN VACCINES

BETACORONAVIRUS mRNA VACCINES

USE OF DENGUE VACCINE IN PREGNANT AND/OR BREASTFEEDING SUBJECTS

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

Vaccines and Antibodies for the Treatment and Prevention of Neurodegenerative Disorders and Inflammation Related Health Conditions

Methods for the Rapid Manufacture of Conjugate Vaccines that Elicit Robust Immune Responses

IMMUNOGENIC COMPOSITIONS COMPRISING AN RSV F PROTEIN TRIMER

BETACORONAVIRUS mRNA VACCINES

POLYNUCLEOTIDES AND LENTIVIRAL VECTORS EXPRESSING NON-STRUCTURAL ANTIGENS OF A FLAVIVIRUS SELECTED FROM THE GROUP OF DENV, ZIKV AND YFV, INDUCING PROTECTIVE CD8+ T-CELL IMMUNITY IN A HOST

MENINGOCOCCUS VACCINES

PEPMIXES TO GENERATE MULTIVIRAL CTLS WITH BROAD SPECIFICITY

CORONAVIRUS VACCINE

LIPID NANOPARTICLE mRNA VACCINES

MODULAR BACTERIOPHAGE T4 NANOPARTICLE PLATFORM ENABLES RAPID DESIGN OF DUAL COVID-19-FLU MUCOSAL VACCINES

MULTIVALENT CARRIERS AND RELATED VACCINE COMPOSITIONS

MEMBRANE VESICLES COMPRISING MULTIPLE INFLUENZA ANTIGENS FOR VACCINES

Immunogenic Compositions of PEGylated Polysaccharide Compounds

PEPTIDE AND NUCLEIC ACID METHODS TO MODULATE DELIVERY OF NUCLEIC ACID STRUCTURES, POLYPEPTIDES, AND THEIR CARGOES

MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO

BIVALENT INACTIVATED EV71-CA16 VACCINE, METHOD FOR PREPARING THE SAME, AND USE THEREOF

Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof

MICELLE COMPRISING AMPHIPHILIC PEPTIDE, AND ANTIGEN CARRIER NANOPARTICLE USING SAME

Combination Vaccine For Prevention Of Influenza And Coronavirus Infections

METHOD FOR PREVENTION AND TREATMENT OF VIRAL DISEASE

IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF

BIOMARKERS AND IMMUNOGENIC COMPOSITIONS FOR FILARIAL PARASITES

Tumor Antigens for Determining Cancer Therapy

IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF

IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES

Recombinant Non-Pathogenic Marek's Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus and Infectious Bursal Disease Virus Antigens

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

SARS-COV-2 VACCINE BOOSTER COMPOSITION

INFLUENZA VACCINES WITH REDUCED AMOUNTS OF SQUALENE

INFLUENZA VIRUS VACCINES AND USES THEREOF

LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND VACCINE FOR THE PREVENTION OF TUBERCULOSIS OR OTHER MYCOBACTERIAL INFECTIONS

METHODS OF MANUFACTURING PEPTIDE-BASED VACCINES

IMMUNOTHERAPEUTIC COMPOSITIONS FOR TREATMENT OF GLIOBLASTOMA MULTIFORME

VACCINE FOR PROTECTION AGAINST LEPTOSPIRA SEROVAR ICTEROHAEMORRHAGIAE

COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS

VARIANT STRAIN-BASED CORONAVIRUS VACCINES

mRNA-based HIV Vaccine For Acute and Latent Infections

HERPES SIMPLEX VIRUS MRNA VACCINES

MULTI-EPITOPE CONSTRUCT

CORONAVIRUS IMMUNOGEN COMPOSITIONS AND THEIR USES

Coxsackievirus B Compositions and Methods Of Use Thereof

POLYVALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE COMPONENT AND APPLICATION THEREOF

COMPOSITIONS, METHODS AND USES FOR ELICITING AN IMMUNE RESPONSE

MUTANT CALR-PEPTIDE BASED VACCINE

PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF HERPES SIMPLEX VIRUS ANTIGENS AND RELATED METHODS

RECOMBINANT FLAVOBACTERIUM COVAE PROTEIN VACCINES

METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES

HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF

NUCLEIC ACID VACCINE AGAINST MONKEYPOX VIRUS AND USE THEREOF

COMPOSITIONS FOR USE IN TREATMENT OF CHLAMYDIA

USES OF MODIFIED RNA ENCODING RETINALDEHYDE DEHYDROGENASE

CD44 GLYCOEPITOPES AND CHIMERIC VACCINE GLYCOCONJUGATES FOR CANCER THERAPY AND SYNTHESIS METHODS THEREOF

IMMUNOGENIC COMPOSITIONS AGAINST INFLUENZA

IMMUNOGENIC COMPOSITIONS AGAINST INFLUENZA

NUCLEOTIDE DELIVERY OF CANCER THERAPY

POLYPEPTIDE FRAGMENTS, IMMUNOGENIC COMPOSITION AGAINST INFLUENZA VIRUS, AND IMPLEMENTATIONS THEREOF

Dual-Action Recombinant Vesicular Stomatitis Virus (RVSV)-Based Vaccine (DAV) Against COVID-19 and Influenza Viruses

RNA COMPOSITIONS FOR DELIVERY OF MONKEYPOX ANTIGENS AND RELATED METHODS

Process for Producing of Vaccine Formulations With Preservatives

MODIFIED PARAPOXVIRUS HAVING INCREASED IMMUNOGENICITY

VACCINE FOR HUMAN T-LYMPHOTROPIC VIRUS-1

RECOMBINANT SUBUNIT BASED UNIVERSAL INFLUENZA AND RESPIRATORY VIRUS VACCINES

IMMUNOGENIC COMPOSITIONS AND METHODS FOR REDUCING TRANSMISSION OF PATHOGENS

MULTIVALENT PNEUMOCOCCAL VACCINES

MODIFIED CORONAVIRUS S PROTEIN

VACCINE AGAINST INFECTIOUS BRONCHITIS

MULTIVALENT DISPLAY ON ENVELOPED PARTICLES WITH HUMAN OLIGOMERIZATION DOMAINS

SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES

Staphylococcal protein variants and truncates

LIPID NANOPARTICLE mRNA VACCINES

Antigenic Epstein Barr Virus Polypeptides

VACCINATION AGAINST BACTERIAL AND BETACORONAVIRUS INFECTIONS

STAPHYLOCOCCUS AUREUS VACCINE COMPOSITIONS

CTA VACCINE CASSETTES

RECOMBINANT CEDAR VIRUS CHIMERAS

Filovirus Consensus Antigens, Nucleic Acid Constructs and Vaccines Made Therefrom, and Methods of Using Same

PNEUMOCOCCAL CONJUGATE VACCINES AND METHODS OF USE THEREOF

RECOMBINANT PLASMID, IMMUNOGENIC COMPOSITION, KIT AND USES THEREOF

ALPHAVIRUS ANTIGEN VECTORS

SARS-CoV-2 VACCINE COMPOSITIONS

COMPOSITIONS AND METHODS OF VACCINATION AGAINST DENGUE VIRUS IN CHILDREN AND YOUNG ADULTS

METHODS AND RELATED ASPECTS FOR INCREASING ANTIGENIC INSERTION SITES ON A RECOMBINANT IMMUNE COMPLEX PLATFORM

COMBINED VACCINE AGAINST MYCOBACTERIUM TUBERCULOSIS

POLYVALENT VACCINES FOR STAPHYLOCOCCAL & STREPTOCOCCAL INFECTION

MULTIVALENT VACCINE COMPOSITIONS AND USES THEREOF

PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS

Method for Preparing Outer Membrane Vesicles

NOVEL RNA AND DNA TECHNOLOGY FOR VACCINATION AGAINST ALPHAVIRUSES AND OTHER EMERGING AND EPIDEMIC VIRUSES

MULTIVALENT MOPEVAC-BASED IMMUNOGENIC COMPOSITION FOR VACCINATION AGAINST NEW WORLD ARENAVIRUSES AND THERAPEUTIC USE(S) THEREOF

VACCINE COMPOSITION AGAINST TWO RESPIRATORY VIRUSES

NUCLEIC ACID VACCINES FOR VARICELLA ZOSTER VIRUS (VZV)

VIRAL PROTEINS AND NANOSTRUCTURES AND USES THEREOF

RECOMBINANT NEWCASTLE DISEASE VIRUSES AND IMMUNOGENIC COMPOSITIONS FOR USE IN PREVENTING COVID-19

Multivalent Vaccine Compositions

MESSENGER RIBONUCLEIC ACIDS FOR ENHANCING IMMUNE RESPONSES AND METHODS OF USE THEREOF

MULTIVALENT VACCINE FOR PARAMYXOVIRUSES AND USES THEREOF

SIGNAL SEQUENCES FOR NUCLEIC ACID VACCINES

AUTOLOGOUS CELL BASED SARS-COV-2 VACCINES

METHODS AND COMPOSITIONS FOR VACCINATION AGAINST HETEROSUBTYPIC INFLUENZA VIRUSES USING AN ADENOVIRAL VECTOR LEADING TO ENHANCED T CELL RESPONSE THROUGH AUTOPHAGY

METHODS AND COMPOSITIONS FOR MULTIVALENT VACCINES

Neisseria Meningitidis Vaccine

EPITOPE FOCUSING BY VARIABLE EFFECTIVE ANTIGEN SURFACE CONCENTRATION

INTRANASAL IMMUNOGENIC COMPOSITIONS

CONCATEMERIC PEPTIDE EPITOPE RNAS

IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF

TUMOR CELL VACCINES

COMPOSITIONS FOR INDUCING INTRATUMORAL IMMUNE TRIADS AND USES THEREOF

IMMUNOGENIC FUSION PROTEIN

BETACORONA VIRUS mRNA VACCINES

BETACORONAVIRUS mRNA VACCINES

VACCINE COMPOSITIONS AND THEIR USE

INFLUENZA VIRUS HEMAGGLUTININ PROTEINS AND USES THEREOF

NOVEL VACCINES AGAINST HPV AND HPV-RELATED DISEASES

EXTRACELLULAR VESICLES FOR THERAPY

HYBRID FLU-CORONAVIRUS VACCINE

HIV VACCINES AND METHODS OF USING

MULTIVALENT OSPA POLYPEPTIDES AND METHODS AND USES RELATING THERETO

Viral Vaccines

RESPIRATORY SYNCYTIAL VIRUS VACCINE

CLOSTRIDIUM CHAUVOEI VACCINE AND METHOD OF MAKING

HENIPAVIRUS VACCINE

INFLUENZA VIRUS MUTANTS AND USES THEREFOR

RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES

MODIFIED BIOTIN-BINDING PROTEIN, FUSION PROTEINS THEREOF AND APPLICATIONS

THERAPEUTIC PAPILLOMA VIRUS VACCINES

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

A MAPS VACCINE TARGETING SALMONELLA ENTERICA SEROVARS

HER-1, HER-3 AND IGF-1R COMPOSITIONS AND USES THEREOF

FOWL ADENOVIRUS SUBUNIT VACCINE AND PRODUCTION METHOD THEREOF

VACCINE COMPOSITION

Rhinovirus Vaccine

VACCINES AGAINST INFECTIOUS DISEASES CAUSED BY POSITIVE STRANDED RNA VIRUSES

Multicistronic Vaccine and Methods for Producing and Using the Same

HIV VACCINES AND METHODS OF USING

RECOMBINANT MULTIVALENT VACCINE

POLYVALENT VACCINES AND METHODS FOR MAKING THEM

RATIONALLY DESIGNED IMMUNOGENS

HEXAVALENT NOROVIRUS VLP VACCINE AND A PREPARATION METHOD THEREOF

IMMUNE CHECKPOINT INHIBITOR CO-EXPRESSION VECTORS

Compositions and Methods for Dengue Virus Chimeric Constructions in Vaccines

SYSTEM AND METHOD

MULTIVALENT CARRIERS AND RELATED VACCINE COMPOSITIONS

COMBINATION RESPIRATORY MRNA VACCINES

IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF

MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION, AND METHODS AND USES THEREOF

MULTIEPITOPE SELF-ASSEMBLED NANOPARTICLE VACCINE PLATFORM (MSN-VACCINE PLATFORM) AND USES THERE OF

SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES

Multi-Epitope Vaccine Platform

HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES

MULTIVALENT VACCINE COMPOSITION FOR PREVENTION OF PORCINE MYCOPLASMA AND PORCINE CIRCOVIRUS INFECTIONS

Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition

PSEUDORABIES VIRUS (PRV) EXPRESSING PORCINE CIRCOVIRUS 2 (PCV2) CAPSID PROTEIN ON ENVELOPE AND USE THEREOF

FELINE LEUKEMIA VIRUS VACCINE

COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF

MULTIVALENT PNEUMOCOCCAL VACCINES

VACCINATION IN ELDERLY PATIENTS

COMPOUNDS AND ADJUVANT FORMULATIONS USEFUL IN PNEUMOCOCCAL VACCINES

SURVIVIN AND MAGE-A9 DUAL-TARGETED IMMUNOTHERAPY

VIRUS VACCINE

MULTIVALENT VIRAL PARTICLES

COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR MULTIVALENT IMMUNE RESPONSES

VACCINE COMPOSITIONS

Universal Influenza Vaccine and Methods of Use

Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof

COMPOSITIONS FOR USE IN TREATMENT OF ACNE

PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF VIRAL ANTIGENS AND RELATED METHODS

VIRAL-LIKE PARTICLES FOR THE TREATMENT OR PREVENTION OF AN INFECTION BY A CORONAVIRIDAE VIRUS

CORONAVIRUS VACCINE

COMBINATION HMPV/RSV RNA VACCINES

Betacoronavirus RNA vaccines

BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE

CONJUGATED VACCINE CARRIER PROTEINS

VACCINES AND COMPOSITIONS BASED ON SARS-COV-2 S PROTEIN

COMBINATION HMPV/RSV RNA VACCINES

VIRUS-LIKE PARTICLE VACCINE FOR RESPIRATORY SYNCYTIAL VIRUS

METHODS FOR IMPROVING THE ADSORPTION OF POLYSACCHARIDE-PROTEIN CONJUGATES AND MULTIVALENT VACCINE FORMULATION OBTAINED THEREOF

TEMPERATURE-CONTROLLABLE, RNA IMMUNOTHERAPEUTIC FOR CANCER

Therapeutic Anticancer Neoepitope Vaccine

Anti-Abeta Therapeutic Vaccines

EFFICIENT VACCINE

COMBINATION HMPV/RSV RNA VACCINES

Influenza virus hemagglutinin proteins and uses thereof

MULTIVALENT PAN-INFLUENZA VACCINE

CORONAVIRUS AND INFLUENZA COMPOSITIONS AND METHODS FOR USING THEM

Recombinant Severe Acute Respiratory Syndrome Coronavirus 2 Rbd Trimer Protein Vaccine Capable Of Generating Broad-Spectrum Cross Neutralization Activity, and Preparation Method and Use Thereof

COMPOSITIONS AND METHODS TARGETING FILAMENTOUS BACTERIOPHAGE

PURIFIED CAPSULAR POLYSACCHARIDES OF STREPTOCOCCUS PNEUMONIAE

VACCINE FOR PROTECTION AGAINST ETEC-INDUCED DIARRHEA COMPRISING DMLT

NON-HLA RESTRICTED T CELL VACCINE FOR TCR GAMMA ALTERNATE READING FRAME PROTEIN (TARP) PROTEIN EXPRESSING CANCERS

T CELL ACTIVATING IMMUNOTHERAPEUTIC FOR TREATMENT OF MUCIN 1 PROTEIN EXPRESSING HUMAN CANCERS

NOROVIRUS S PARTICLE BASED VACCINES AND METHODS OF MAKING AND USING SAME

COMPOSITIONS AND METHODS OF TREATING PLASMA CELL DISORDERS INCLUDING MULTIPLE MYELOMA WITH A VACCINE COMPOSITION AND MYELOMA-SPECIFIC CAR-T CELLS

RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING A CHIMERIC RSV/PIV3 F PROTEIN AND USES THEREOF

NOVEL CORONAVIRUS VACCINE BASED ON CONTROLLABLE SECRETORY EXPRESSION OF ATTENUATED SALMONELLA, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

Compositions for use in treatment of

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

METHOD FOR THE TREATMENT OF PATIENTS WITH CARCINOMAS

VIRUS-INSPIRED COMPOSITIONS AND METHODS OF REDIRECTING PREEXISTING IMMUNE RESPONSES USING THE SAME FOR TREATMENT OF CANCER

PORCINE BIVALENT SUBUNIT VACCINE COMPOSITION IN A SINGLE DOSE

MULTIVALENT INFLUENZA NANOPARTICLE VACCINES

EBOLAVIRUS AND MARBURGVIRUS VACCINES

Universal mRNA Vaccine to Treat Dementia-Causing Neurodegenerative Disorders

HYBRID MULTIVALENT INFLUENZA VACCINES COMPRISING HEMAGGLUTININ AND NEURAMINIDASE AND METHODS OF USING THE SAME

VACCINE

Coronavirus vaccine

MULTIVALENT INFLUENZA VACCINES COMPRISING RECOMBINANT HEMAGGLUTININ AND NEURAMINIDASE AND METHODS OF USING THE SAME

COVID-19 VACCINES WITH TOCOPHEROL-CONTAINING SQUALENE EMULSION ADJUVANTS

TEMPERATURE-CONTROLLABLE, SELF-REPLICATING RNA VACCINES FOR VIRAL DISEASES

BROAD-SPECTRUM MULTI-ANTIGEN PAN-CORONAVIRUS VACCINE

MULTIVALENT INFLUENZA VACCINES

ADJUVANT AND VACCINE CONTAINING ADJUVANT

Respiratory syncytial virus mRNA vaccine

METHODS FOR PRODUCING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CARRIER PROTEIN CONJUGATES

MESENCHYMAL STEM CELLS AS VACCINE ADJUVANTS AND METHODS FOR USING THE SAME

RECOMBINANT HVT VECTORS EXPRESSING INFLUENZA HEMAGGLUTININ AND IMMUNOGENIC COMPOSITIONS, AND PRODUCTION AND USES THEREOF

HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF

CORONAVIRUS SPIKE PROTEIN DESIGNS, COMPOSITIONS AND METHODS FOR THEIR USE

VACCINES AGAINST RESPIRATORY DISEASES

IMMUNE CHECKPOINT MULTIVALENT PARTICLES COMPOSITIONS AND METHODS OF USE

APPLICATION OF ARTIFICIALLY SYNTHESIZED CPG SINGLE-STRANDED DEOXYOLIGONUCLEOTIDE IN VACCINES

COMBINATIONS OF VIRAL PROTEINS, PEPTIDE SEQUENCES, EPITOPES, AND METHODS AND USES THEREOF

IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES

MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION

COMPOSITIONS AND METHODS FOR IDENTIFICATION OF CROSS-REACTIVE ALLERGENIC PROTEINS AND TREATMENT OF ALLERGIES

INFLUENZA-CORONAVIRUS COMBINATION VACCINES

Vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus

TETRAVALENT DENGUE INACTIVATED VACCINE

Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof

VACCINE

PERIODONTITIS VACCINE AND RELATED COMPOSITIONS AND METHODS OF USE

NOVEL MULTIVALENT NANOPARTICLE-BASED VACCINES

MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES

Universal vaccine platform

RESPIRATORY VIRUS COMBINATION VACCINES

NEOGLYCOCONJUGATES AS VACCINES AND THERAPEUTIC TOOLS

CORONAVIRUS ANTIBODY

COMPOSITIONS AND METHODS FOR PREVENTING RSV AND PIV3 INFECTIONS

Liquid six combined vaccine composition

NIPAH VIRUS IMMUNOGENS AND THEIR USE

Vaccination with mRNA-coded antigens

A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS SEROTYPE 9, SEQUENCE TYPE 16

Compositions and Methods of Manufacturing Trivalent Filovirus Vaccines

Personalized Site-Specific Immunomodulation

SARS-COV-2 VACCINE COMPOSITION AND USE THEREOF

Adenovirus SARS-CoV-2 Vaccine

CLADE C HIV-1 ENVELOPE (ENV) TRIMER IMMUNOGENS, COMPOSITIONS INCLUDING THE CLADE C HIV-1 ENVELOPE (ENV) TRIMER IMMUNOGENS, AND USES THEREOF

PERTUSSIS VACCINE

TARGETING MULTIPLE T CELL TYPES USING SPHERICAL NUCLEIC ACID VACCINE ARCHITECTURE

mRNA VACCINE COMPOSITIONS AND THEIR USE

COMPOSITIONS AND METHODS FOR IDENTIFICATION OF CROSS-REACTIVE ALLERGENIC PROTEINS AND TREATMENT OF ALLERGIES

TETRAVALENT DENGUE INACTIVATED VACCINE

Formulations of dengue virus vaccine compositions

Periodontitis vaccine and related compositions and methods of use

Recombinant Non-Pathogenic Marek's Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus and Infectious Bursal Disease Virus Antigens

PARTICLES ENCAPSULATING FUSION PROTEINS CONTAINING LINKED EPITOPES

VACCINE AND METHODS FOR PREVENTING FILARIASIS AND DIROFILARIASIS

Compositions comprising polysaccharide-protein conjugates and methods of use thereof

OPTIMIZED HOST/VECTOR SYSTEM FOR PRODUCING PROTECTIVE MONO- AND MULTIVALENT SUBUNIT VACCINES ON THE BASIS OF THE YEAST KLUYVEROMYCES LACTIS

PORCINE CIRCOVIRUS TYPE 3 IMMUNOGENIC COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

COMBINED VACCINE AGAINST HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTIONS AND METHOD THEREOF FOR INDUCING IMMUNE RESPONSE

MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNIZING AVIAN SPECIES

Epstein-Barr Virus antigen constructs

STABLE FORMULATION OF HUMAN PAPILLOMAVIRUS VIRUS-LIKE PARTICLE VACCINE

Unified platform for rapid production of nanovaccines with enhanced safety, efficacy and precision

VACCINES FOR THE TREATMENT AND PREVENTION OF SEASONAL AND EMERGING INFECTIONS

Vaccines against HPV and HPV-related diseases

TUMOR ANTIGENS, COMPOUNDS COMPRISING THE TUMOR ANTIGENS AND USES THEREOF

Modified biotin-binding protein, fusion proteins thereof and applications

Alphavirus neoantigen vectors

Coronavirus vaccine

IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES

PEPTIDE VACCINES

Influenza vaccines

MENINGOCOCCUS VACCINES

Biomarkers and immunogenic compositions for filarial parasites

VACCINE

MVA vaccine for delivery of a UL128 complex and preventing CMV infection